TrialSignal transduction and targeted therapy2020

Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma.

Jun Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.